Test filters | DNDi

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

In the media

2 Dec 2025

“Como si me comiera desde dentro”: la enfermedad que ataca los huesos en el norte de Kenia

EFE

Scientific articles

2 Dec 2025

The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities

Parasites & Vectors

Press releases

27 Nov 2025

International seminar explores the development of treatments for dengue for populations not covered by vaccines

News

26 Nov 2025

DNDi statement on the approval of the Instituto Butantan’s dengue vaccine and the need for a dengue treatment

Scientific articles

25 Nov 2025

Bidirectional interaction between liposomal amphotericin B pharmacokinetics and parasite dynamics in patients with post-kala-azar dermal leishmaniasis: Potential implications for optimal dosing

Clinical Pharmacology & Therapeutics

Videos

24 Nov 2025

Interview with Dr Pauline Williams, new DNDi Scientific Advisory Committee (SAC) Chair

Scientific articles

20 Nov 2025

Leishmaniasis

Nature Reviews Disease Primers

Scientific articles

20 Nov 2025

Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants

British Journal of Clinical Pharmacology

Viewpoints

20 Nov 2025

Neglecting infectious diseases is a market failure

Financial Times

Videos

20 Nov 2025

Beni: Surviving Sleeping Sickness

Publications

17 Nov 2025

Open Science in a Closed World

News

17 Nov 2025

New DNDi report: Open science in a closed world – lessons and opportunities for securing openness and equitable access in R&D collaborations

In the media

16 Nov 2025

Fra flue til flue har denne fjende hærget Afrika. Men nu er sejren mod sovesyge lige om hjørnet

Verdens Bedste Nyheder

Statements

13 Nov 2025

Joint statement by CEPI, DNDi, MMV, and Unitaid on the Belém Health Action Plan (BHAP)

In the media

12 Nov 2025

Varios activistas climáticos invaden el área restringida de la COP30 durante una protesta

EFE

In the media

11 Nov 2025

Policies to promote affordability and access across the life cycle of costly new drugs

The BMJ

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

“Como si me comiera desde dentro”: la enfermedad que ataca los huesos en el norte de Kenia

The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities

International seminar explores the development of treatments for dengue for populations not covered by vaccines

DNDi statement on the approval of the Instituto Butantan’s dengue vaccine and the need for a dengue treatment

Bidirectional interaction between liposomal amphotericin B pharmacokinetics and parasite dynamics in patients with post-kala-azar dermal leishmaniasis: Potential implications for optimal dosing

Interview with Dr Pauline Williams, new DNDi Scientific Advisory Committee (SAC) Chair

Leishmaniasis

Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants

Neglecting infectious diseases is a market failure

Beni: Surviving Sleeping Sickness

Open Science in a Closed World

New DNDi report: Open science in a closed world – lessons and opportunities for securing openness and equitable access in R&D collaborations

Fra flue til flue har denne fjende hærget Afrika. Men nu er sejren mod sovesyge lige om hjørnet

Joint statement by CEPI, DNDi, MMV, and Unitaid on the Belém Health Action Plan (BHAP)

Varios activistas climáticos invaden el área restringida de la COP30 durante una protesta

Policies to promote affordability and access across the life cycle of costly new drugs

Learn more

Get in touch

Support us

Work with us